Review of erlotinib in the treatment of advanced non-small cell lung cancer
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
[PDF][PDF] Review of erlotinib in the treatment of advanced non-small cell lung cancer
KN Ganjoo - Biologics: Targets & Therapy, 2007 - Citeseer
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
[PDF][PDF] Review of erlotinib in the treatment of advanced non-small cell lung cancer
KN Ganjoo - Biologics: Targets & Therapy, 2007 - researchgate.net
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
[HTML][HTML] Review of erlotinib in the treatment of advanced non-small cell lung cancer
KN Ganjoo, H Wakelee - Biologics: Targets & Therapy, 2007 - ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
Review of erlotinib in the treatment of advanced non-small cell lung cancer
KN Ganjoo, H Wakelee - Biologics, 2007 - search.proquest.com
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
Review of erlotinib in the treatment of advanced non-small cell lung cancer.
KN Ganjoo, H Wakelee - Biologics: Targets & Therapy, 2007 - europepmc.org
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
[PDF][PDF] Review of erlotinib in the treatment of advanced non-small cell lung cancer
KN Ganjoo - Biologics: Targets & Therapy, 2007 - scholar.archive.org
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
Review of erlotinib in the treatment of advanced non-small cell lung cancer
KN Ganjoo - Biologics: Targets & Therapy, 2007 - dovepress.com
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
Review of erlotinib in the treatment of advanced non-small cell lung cancer
KN Ganjoo, H Wakelee - Biologics: targets & therapy, 2007 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
Review of erlotinib in the treatment of advanced non-small cell lung cancer.
KN Ganjoo, H Wakelee - Biologics: Targets & Therapy, 2007 - europepmc.org
Epidermal growth factor receptor (EGFR) is a transmembrane receptor with a cytoplasmic
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …
tyrosine kinase (TK) domain present on many solid tumors including non-small cell lung …